ArticleHypertension research : official journal of the Japanese Society of Hypertension2020

Synergistic reduction in albuminuria in type 2 diabetic mice by esaxerenone (CS-3150), a novel nonsteroidal selective mineralocorticoid receptor blocker, combined with an angiotensin II receptor blocker.

Kiyoshi Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.